← Back to Search

Tissue Collection for Cancer

N/A

Recruiting

Led By Aaron S. Mansfield, M.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 years post tissue and blood collection

Awards & highlights

Study Summary

This trial is collecting tumor specimens in order to improve outcomes for patients with cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 years post tissue and blood collection

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 years post tissue and blood collection

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 years post tissue and blood collection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants accrued with genomic, microbiome, and drug sensitivity components of aggressive cancer.

Secondary outcome measures

Determine number of participants with genomic, microbiome and drug sensitivity assays (profile or functional) that suggest changes to treatment plan.

Trial Design

3Treatment groups

Experimental Treatment

Group I: Tissue CollectionExperimental Treatment1 Intervention

Research tissue specimen will be obtained during the patient's clinical biopsy or clinical tumor resection, if feasible.

Group II: Buccal SwabExperimental Treatment1 Intervention

Buccal swab may be requested, if necessary, to generate germline data.

Group III: Blood CollectionExperimental Treatment1 Intervention

Up to 50 mL of research blood will be drawn around the time of the procedure. Additional blood may be collected in selected cases, as warranted, to monitor disease recurrence/remission or perform additional testing

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Tissue Collection

2010

N/A

~70

Blood Collection

2014

Completed Phase 4

~7010

Buccal Swab

2006

N/A

~1890

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,206 Previous Clinical Trials

3,767,033 Total Patients Enrolled

Aaron S. Mansfield, M.D.Principal InvestigatorMayo Clinic

1 Previous Clinical Trials

50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research currently available?

"Data available on clinicaltrials.gov attests to the fact that this medical trial is still searching for volunteers. It was originally posted on April 6th 2022 and last updated May 12th of the same year."

Answered by AI

What has been the total enrollments rate of this research?

"That is correct. Clinicaltrials.gov indicates that this medical trial, which was published on April 6th 2022, is actively recruiting individuals for participation. 50 patients are required from 1 centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Patient Derived Preclinical Models

2022. "Patient Derived Preclinical Models". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05324553.